Blue Fin Group
Blue Fin Group is a privately held US management and consulting firm serving the pharmaceutical and biotechnology industry. Founded in 2001 and headquartered in New York, it operates with 101-250 employees as a mid-sized specialist life-sciences consultancy.
- Company typePrivate
- Founded2001
- HeadquartersNew York, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Blue Fin Group does
Blue Fin Group is a privately held management and consulting firm serving the pharmaceutical and biotechnology industry. According to available firmographic data, the company was founded in 2001, is headquartered in New York, United States, and operates with a headcount of 101-250 employees—placing it in the mid-sized specialist consultancy tier rather than among global generalist advisory firms. Its self-description characterizes the business as management consulting for pharma and biotech, but the underlying service lines (e.g., commercial strategy, market access, operations, launch readiness), engagement model, and technology stack could not be verified from the supplied sources.
The primary website (consultbfg.com) returned only a verification/loading page during data collection, and no press releases, case studies, customer references, or third-party coverage were available to substantiate product details, pricing structure, or go-to-market mechanics. Consequently, whether Blue Fin Group operates on a pure advisory (time-and-materials or fixed-fee consulting) basis, retains proprietary tools or frameworks, or has expanded into productized offerings cannot be determined from the evidence on hand. The 24 years of operating history and a 101-250 employee footprint imply a mature, established practice rather than an early-stage venture, but no financial, growth, or strategic-move data is present to corroborate this.
For an investment audience, the key takeaway is that the firm sits in a defensible niche (life-sciences management consulting) but the supplied evidence is too thin to support deeper diligence conclusions on revenue, customer base, competitive positioning, or growth trajectory without primary research.
Blue Fin Group firmographics
Firmographics- Name
- Blue Fin Group
- Website
- https://consultbfg.com
- Company type
- Private
- Founded year
- 2001
- Headcount range
- 101–250 employees
- Short description
- Blue Fin Group is a privately held US management and consulting firm serving the pharmaceutical and biotechnology industry. Founded in 2001 and headquartered in New York, it operates with 101-250 employees as a mid-sized specialist life-sciences consultancy.
- Ownership category
- akta.pro rank
Blue Fin Group industry classification
Industry- Product category
- Pharmaceutical Consulting
- akta.pro primary industry
- Corporate Finance & Capital Advisory (BPAHADAB)
Keywords
Where Blue Fin Group is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Markets served
Blue Fin Group business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Blue Fin Group product offering
Product offeringCore offering
Blue Fin Group is a management and consulting company that provides advisory services to clients in the pharmaceutical and biotechnology industry. The firm supports pharma and biotech organizations with management consulting engagements from its New York headquarters.
Product overview
No product or service information for Blue Fin Group was found in the provided source data. The available sources do not contain specific details about Blue Fin Group's offerings, product portfolio, or service descriptions.
Differentiator
Problem solved
Functional benefit
Products and services
- Management Consulting Services Advisory and management consulting services delivered to pharmaceutical and biotechnology companies, supporting business and strategic needs across the life-sciences value chain.
Companies that use Blue Fin Group
Customer profileIdeal customer profiles1 record
Blue Fin Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Blue Fin Group competitors and assessment
Company assessmentDirect peers
- ZS Associates: Global consulting firm specialized in the pharmaceutical and biotech industry with deep commercial, R&D, and analytics practices. Directly comparable to BFG in vertical specialization and pharma-focused advisory offerings.
- Putnam Associates: Boutique-to-mid-sized consulting firm focused exclusively on the life-sciences industry with strategy and commercial practice areas. Direct peer in vertical specialty and firm-size profile.
- LEK Consulting: Global strategy consulting firm with one of the strongest dedicated life-sciences practices (LEK Healthcare). Competes with BFG for similar pharma and biotech strategy engagements.
- Charles River Associates: Consulting firm with a prominent life-sciences practice serving pharma and biotech clients on commercial strategy, pricing, and litigation support. Comparable in advisory scope and client base.
- Simon-Kucher & Partners: Global consulting firm with leading pharma pricing, market access, and commercial strategy practices. A direct competitor for pharma and biotech clients with a similar specialty lens.
- ClearView Healthcare Partners: Boutique life-sciences strategy consulting firm focused exclusively on pharma, biotech, and medical technology clients. Strong overlap with BFG in niche life-sciences strategy advisory.
Broad incumbents
- IQVIA: The largest scaled provider of pharma and biotech advisory, analytics, and consulting services globally. A broad incumbent whose pharma consulting practice overlaps directly with BFG's positioning.
- McKinsey & Company (Pharmaceuticals & Medical Products Practice): Largest global strategy consultancy with a dedicated pharma and medical products practice that competes for the same enterprise pharma/biotech mandates as BFG, often at larger scale.
- Bain & Company (Healthcare Practice): Top-tier strategy consultancy with a substantial healthcare and life-sciences practice serving pharma and biotech clients on commercial and corporate strategy. A broad incumbent peer.
- Guidehouse (formerly Navigant Consulting): Large advisory firm with a dedicated life-sciences consulting practice covering pharma strategy, operations, and commercialization. Broad incumbent competing for similar pharma engagements.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat2 records
Key risks4 records
Key highlights4 records
Customer concentration
Blue Fin Group social profiles
Digital presenceBlue Fin Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Blue Fin Group leadership team
Management profileNumber of profiles
Blue Fin Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Blue Fin Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Blue Fin Group
What does Blue Fin Group do?
Blue Fin Group is a management and consulting company that provides advisory services to clients in the pharmaceutical and biotechnology industry. The firm supports pharma and biotech organizations with management consulting engagements from its New York headquarters.
When was Blue Fin Group founded?
Blue Fin Group was founded in 2001. It employs 101 to 250 people.
Where is Blue Fin Group based?
Blue Fin Group is headquartered in New York, United States, in the North America region.
Who are Blue Fin Group's main competitors?
Direct peers on record are ZS Associates, Putnam Associates, LEK Consulting, Charles River Associates, Simon-Kucher & Partners and ClearView Healthcare Partners. Broad incumbents are IQVIA, McKinsey & Company (Pharmaceuticals & Medical Products Practice), Bain & Company (Healthcare Practice) and Guidehouse (formerly Navigant Consulting).
Does Blue Fin Group have an API?
No public API is recorded for Blue Fin Group.
What industry is Blue Fin Group in?
Blue Fin Group's product category is Pharmaceutical Consulting. Its primary akta.pro industry code is BPAHADAB, Corporate Finance & Capital Advisory.